Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Vascular Impairment in Type II Diabetes Mellitus With Co-morbid Obstructive Sleep Apnea

This study is currently recruiting participants. (see Contacts and Locations)
Verified October 2016 by University of Pittsburgh
Sponsor:
Collaborators:
Beth Israel Deaconess Medical Center
Brigham and Women's Hospital
National Institutes of Health (NIH)
Information provided by (Responsible Party):
Sanjay R Patel, University of Pittsburgh
ClinicalTrials.gov Identifier:
NCT01629862
First received: May 8, 2012
Last updated: October 31, 2016
Last verified: October 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2016
  Estimated Primary Completion Date: December 2016 (Final data collection date for primary outcome measure)